Inactive Instrument
LYSOGENE Share Price
Stocks
LYS
FR0013233475
Biotechnology & Medical Research
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 09/05/2014 | |
| Director of Finance/CFO | - | 01/11/2022 | |
Marie Trad
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 54 | 22/05/2019 | |
Peter Lichtlen
BRD | Director/Board Member | 58 | 01/04/2018 |
Carole Deffez
BRD | Director/Board Member | - | 26/09/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 55.26L | ||
| -3.13% | -0.57% | +93.21% | +288.25% | 402.98Cr | ||
| -4.66% | -7.69% | +48.07% | +69.38% | 359.19Cr | ||
| -3.26% | +50.23% | +192.38% | -7.65% | 305.3Cr | ||
| +0.15% | +4.13% | +280.26% | +432.36% | 244.75Cr | ||
| +3.97% | +6.34% | -19.72% | -28.79% | 229.61Cr | ||
| -3.75% | +5.87% | +9.27% | - | 130.35Cr | ||
| -0.16% | +13.73% | +17.28% | +44.02% | 102.73Cr | ||
| 0.00% | -9.83% | +114.87% | -44.10% | 86Cr | ||
| +0.75% | +10.50% | -36.33% | -0.10% | 56Cr | ||
| Average | -1.01% | +8.52% | +77.70% | +94.17% | 213.04Cr | |
| Weighted average by Cap. | -1.80% | +10.57% | +98.29% | +133.56% |
Employees
22
















